Bianca Weinstock-Guttman
Jacobs Neurological Institute
100 High Street
Buffalo
NY, 14203-1126
USA
Name/email consistency: high
- Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS. Weinstock-Guttman, B., Galetta, S.L., Giovannoni, G., Havrdova, E., Hutchinson, M., Kappos, L., O'Connor, P.W., Phillips, J.T., Polman, C., Stuart, W.H., Lynn, F., Hotermans, C. J. Neurol. (2012)
- Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. Weinstock-Guttman, B., Zivadinov, R., Mahfooz, N., Carl, E., Drake, A., Schneider, J., Teter, B., Hussein, S., Mehta, B., Weiskopf, M., Durfee, J., Bergsland, N., Ramanathan, M. J. Neuroinflammation (2011)
- Interferon-beta treatment for relapsing multiple sclerosis. Weinstock-Guttman, B., Ramanathan, M., Zivadinov, R. Expert. Opin. Biol. Ther (2008)
- Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica. Weinstock-Guttman, B., Miller, C., Yeh, E., Stosic, M., Umhauer, M., Batra, N., Munschauer, F., Zivadinov, R., Ramanathan, M. Mult. Scler. (2008)
- Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Weinstock-Guttman, B., Ramanathan, M., Lincoff, N., Napoli, S.Q., Sharma, J., Feichter, J., Bakshi, R. Arch. Neurol. (2006)









